Antibacterial Therapy in Adults with COVID-19

Since the emergence of the Coronavirus-19 infectious disease (COVID-19) pandemic, a rising number of reports have underlined the risk of increasing antimicrobial resistance due to antibiotic overuse in COVID-19 patients. In addition, many physicians and pharmacists involved in antimicrobial stewards...

詳細記述

保存先:

書誌詳細
その他の著者:	Allard, Sabine Danielle (編集者), Van Laethem, Johan (編集者)
フォーマット:	電子媒体図書の章
言語:	英語
出版事項:	Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
主題:	Medicine Clinical & internal medicine COVID-19 antimicrobial use multicentre point-prevalence study Influenza co-infection secondary infections aspergillosis ivermectin randomized-controlled trial prevention treatment SARS-CoV-2 antiviral antibiotic azithromycin remdesivir macrolides virus coronavirus immunolides antivirus pandemics procalcitonin SARS virus community-acquired infections emergency service hospital pneumonia viral community-acquired pneumonia Mid-regional Pro-adrenomedullin ARDS biomarker prognosis superinfection bacterial co-infection bacterial superinfection antibiotic stewardship AMR antibiotics cephalosporin secondary infection variant of concern interleukin-6 receptor antagonist early administration mortality rates
オンライン･アクセス:	DOAB: download the publication DOAB: description of the publication
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Antibacterial Therapy in Adults with COVID-19

出版事項 2023

DOAB: download the publication
DOAB: description of the publication

電子媒体図書の章

Antibacterial Therapy in Adults with COVID-19

Antibacterial Therapy in Adults with COVID-19

類似資料